Investor Relations Analyst
Amneal
Summary
Amneal is seeking an Investor Relations Analyst to provide specialized financial analysis, equity-market research, and pharmaceutical competitive intelligence in support of its investor relations program. The role applies financial statement analysis, corporate finance, valuation, and quantitative research to evaluate the Company's performance, market positioning, and long-term value creation opportunity. Working closely with the Head of Investor Relations and cross-functional partners, the Analyst will develop deep knowledge of Amneal's biosimilars business and translate financial, business, and market analysis into insights for investors, the Board of Directors, and senior leadership.
Job description
Strategic IR, Value Creation & Catalyst Planning
- Analyze the financial drivers of the Company's investment narrative and value creation framework, linking growth, profitability, cash generation, capital allocation, and valuation to business strategy.
- Maintain a catalyst roadmap of product launches, pipeline and regulatory milestones, and strategic developments; assess potential implications for financial performance, market expectations, and investor messaging.
- Maintain the integrated IR calendar and press release schedule, aligning earnings, conferences, roadshows, and communications with business priorities, investor interests, and upcoming catalysts.
Investor Targeting & Relationship Management
- Analyze institutional portfolios, investment mandates, sector exposure, and peer ownership to prioritize investor targets; maintain the Top 20 investor priority list and broader targeting universe, including retail.
- Maintain the investor CRM, including contacts, ownership profiles, investment styles, meeting history, feedback, questions, and follow-up actions; use these records to evaluate engagement and refine targeting.
- Prepare research-based investor profiles and meeting briefings; support outreach and follow-up by identifying relevant investment theses, valuation perspectives, and questions from current and prospective shareholders.
Analyst Research, Peer Analysis & Valuation
- Analyze sell-side research, earnings models, consensus estimates, revisions, ratings, and price targets for Amneal and peers; identify underlying assumptions and emerging investor concerns.
- Analyze peer financial statements and quarterly results, including Sandoz, Teva, and Viatris; compare growth, margins, cash flow, leverage, business drivers, strategic developments, and investor messaging.
- Develop and maintain peer benchmarks and financial valuation models, including comparable-company multiples and sensitivity analyses, to evaluate relative performance, valuation gaps, and market expectations.
Market Activity & Shareholder Ownership
- Analyze daily share-price performance, trading volume, and volatility relative to peers and market benchmarks, as necessary; assess potential links to company news, analyst revisions, sector developments, and broader market conditions.
- Analyze institutional ownership changes, concentration, and investor style using shareholder filings and market data; prepare concise market and ownership updates.
Biosimilars & Industry Intelligence
- Develop deep knowledge of Amneal's biosimilars portfolio, pipeline, development milestones, partnerships, manufacturing capabilities, and commercial strategy.
- Evaluate biosimilar competitive dynamics, new entrants, pipelines, expected launches, regulatory developments, pricing, adoption, and addressable markets; assess potential implications for Amneal's growth and competitive positioning.
- Develop market and pipeline trackers and financial scenario analyses using documented launch-timing, market-share, and pricing assumptions; translate findings into investment-relevant insights and management briefings.
- Monitor GLP-1 and specialty medicine developments relevant to Amneal's investment narrative, including new specialty R&D therapeutic initiatives; validate business assumptions with internal subject-matter experts.
Investor Communications & IR Execution
- Prepare financial analysis and supporting content for earnings releases, presentations, scripts, Q&A, investor materials, and IR website updates; validate figures and reconcile approved financial measures with Finance.
- Support earnings calls, conferences, roadshows, investor days, and other IR events, including research, briefing materials, logistics, and follow-up.
- Research investor questions and synthesize financial and industry information into proposed responses; coordinate with Finance, business leaders, and Legal to ensure accuracy and appropriate disclosure.
Board of Directors & Executive Leadership Communications
- Support preparation of analytical reports and presentations for the Board of Directors and Executive Leadership Team (ELT), integrating valuation, trading, ownership, analyst perspectives, investor feedback, engagement, and upcoming catalysts.
- Synthesize internal business updates and external research into conclusions on performance, risks, opportunities, and market perceptions; conduct ad hoc IR analyses and recommend communication priorities for senior leadership.
Requirements
- Bachelor's Degree (BA/BS) in Finance or closely related specialized field with coursework in financial statement analysis, corporate finance, valuation, and capital markets
- Business Administration degree must include relevant finance or accounting concentration
- 3 years or more in investor relations, equity research, investment banking, capital markets, corporate finance, or related analytical role
- 1 year or more experience in a publicly traded company, financial institution, or financial services firm
- Demonstrated application of financial statement analysis, corporate valuation, financial modeling, and quantitative capital-markets research
- Advanced Excel skills
- Strong PowerPoint skills
- Excellent written and verbal communication skills
- Highly organized and detail-oriented with strong project management skills
- Ability to manage multiple priorities in a fast-paced environment
- Intellectual curiosity, initiative, and sound judgment
- Ability to work independently and collaborate across functions
- Ability to engage with senior leadership and handle confidential information appropriately
- Familiarity with financial data platforms such as FactSet or Bloomberg
- Familiarity with investor CRM tools
Benefits
- Health Insurance
- Insurance Benefits
- 401(k) Matching
- Employee Well-being Programs
Company overview
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is a leading American publicly traded pharmaceutical company headquartered in Bridgewater, New Jersey. Founded in 2002 by brothers Chirag and Chintu Patel, the company has grown to become one of the largest and fastest-growing generic pharmaceutical manufacturers in the United States. Amneal operates as an integrated pharmaceutical company focused on developing, manufacturing, and distributing generic, brand, and biosimilar products. With approximately 8,100 employees globally, the company maintains operations across North America, Asia, and Europe. Amneal's business is organized into three main segments: a robust U.S. generics business with over 250 product families, a growing specialty pharmaceuticals division focused on central nervous system disorders and endocrine conditions, and an expanding biosimilars portfolio. The company has established itself as a leader in complex dosage forms and difficult-to-manufacture products, with manufacturing capabilities spanning oral solids, injectables, ophthalmics, liquids, topicals, transdermals, and respiratory devices. Amneal's mission 'We make healthy possible' reflects its commitment to providing affordable access to essential medicines while maintaining high-quality standards across its global operations.